Published

Policy in focus: Is psilocybin the next cannabis?

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: Canadian Medical Association Journal
Date: 2021-10-31
Source: Europe PMC
DOI: 10.1503/cmaj.1095974
PubMed: 34782381

Authors

Basky G.

Watch author

Topics and keywords

psilocybin General Other Humans Hallucinogens Combined Modality Therapy Mental Disorders Psychotherapy Health Policy Canada United States Medical Marijuana Psilocybin

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Policy in focus: Is psilocybin the next cannabis?2021-10-31

Related papers

Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-26 Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventionsJournal of Psychedelic Studies · 2026-07-02 S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-18 A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.Psychotherapy · 2025-01-12 Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?Trends in Psychiatry and Psychotherapy · 2024-12-31 A new behavior change program using psilocybin.Psychotherapy · 1964-12-31 Supplemental Material for A Critical Evaluation of Psilocybin-Assisted Therapy Protocol Components From Clinical Trial Patients, Facilitators, and CaregiversPsychotherapy · 2024-12-31